Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for NTRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 143.61M
March 31, 2026 142.73M
December 31, 2025 139.69M
September 30, 2025 137.53M
June 30, 2025 136.76M
March 31, 2025 135.93M
December 31, 2024 132.65M
September 30, 2024 124.14M
June 30, 2024 123.36M
March 31, 2024 122.23M
December 31, 2023 119.58M
September 30, 2023 118.99M
June 30, 2023 114.05M
March 31, 2023 113.36M
December 31, 2022 111.26M
September 30, 2022 97.30M
June 30, 2022 96.90M
March 31, 2022 96.26M
December 31, 2021 95.14M
September 30, 2021 94.54M
June 30, 2021 88.50M
March 31, 2021 87.43M
December 31, 2020 86.22M
Date Value
September 30, 2020 85.28M
June 30, 2020 79.72M
March 31, 2020 78.65M
December 31, 2019 78.00M
September 30, 2019 70.85M
June 30, 2019 70.04M
March 31, 2019 63.34M
December 31, 2018 62.08M
September 30, 2018 61.67M
June 30, 2018 55.45M
March 31, 2018 54.25M
December 31, 2017 54.04M
September 30, 2017 53.71M
June 30, 2017 53.21M
March 31, 2017 52.81M
December 31, 2016 52.66M
September 30, 2016 52.38M
June 30, 2016 51.78M
March 31, 2016 51.26M
December 31, 2015 50.35M
September 30, 2015 49.95M
June 30, 2015 48.98M
March 31, 2015 49.93M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Guardant Health, Inc. 133.61M
CareDx, Inc. 51.48M
Myriad Genetics, Inc. 95.60M
BioRestorative Therapies, Inc. 1.274M
Exagen, Inc. 24.19M